Fusen Pharmaceutical Company Ltd. announced a change of auditor after KPMG resigned from its role effective 24 December 2025, citing an inability to reach a consensus on the proposed audit fee for the company's 2025 consolidated financial statements. The company stated there was no disagreement with KPMG aside from the fee issue, and no other matters needed to be brought to shareholders' attention. CCTH CPA Limited has been appointed as the new auditor. The board believes this change will not materially affect the company's annual audit or the release of its annual results for 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fusen Pharmaceutical Company Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251224-11966910), on December 24, 2025, and is solely responsible for the information contained therein.